Krystal Biotech, Inc. KRYS Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s total operating expenses?
- Krystal Biotech, Inc. (KRYS) reported total operating expenses of $62.67M in Q1 2026.
- How has Krystal Biotech, Inc.'s total operating expenses changed year-over-year?
- Krystal Biotech, Inc.'s total operating expenses increased by 20.7% year-over-year, from $51.93M to $62.67M.
- What is the long-term trend for Krystal Biotech, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Krystal Biotech, Inc.'s total operating expenses has grown at a 35.2% compound annual growth rate (CAGR), from $68.27M to $227.93M.
- What does total operating expenses mean?
- The total cost of operating the business, including production, research, and administration.
- How do you interpret total operating expenses?
- A lower ratio of total operating expenses to revenue indicates strong operational efficiency and scalability.
- How does total operating expenses compare across companies?
- Standard metric for evaluating the total cost burden of a business model.